Abstract
In most cases of lymphomas with blood dissemination, the careful cytological analysis of peripheral blood smears provides a rapid orientation to diagnosis, even if the final subtyping is achieved by histology and eventually other techniques. Here, we evaluated if the analysis of blood smears may suggest the blood dissemination of angioimmunoblastic T-cell lymphoma (AITL) and if CD10 expression on neoplastic T cells, as recently reported on AITL, may contribute to the diagnosis. In all, 11 lymph nodes and six peripheral blood samples from 12 patients with AITL were studied using four-colour flow cytometry associated to histological, cytological and molecular data. According to previous results, a fraction of T cells expressed CD10 in 10/11 lymph nodes. Interestingly, all blood smears showed atypical lymphoid cells and a fraction of T cells expressed CD10 with a mean percentage of 18.75% (range 5.00–47.00%), regardless of lymphocytosis level and of rate of CD10 T cells in corresponding lymph node. In contrast, in all control samples (100), none CD10-positive T cell was identified. This is to our knowledge the first description of circulating CD10 neoplastic T cells in AITL. Therefore, they ought to be explored in further studies when aggressive lymphoma, in particular with lymphopenia and circulating atypical cells, is suspected.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jaffe ES, Ralfkiaer E . Angioimmunoblastic lymphoma. In: Jaffe E, Harris N, Stein S, Vardiman J (eds). World Health Organisation Classification of Tumours: Tumours of the Haemaopoietic and Lymphoid Tisues. IARC Press: Lyon, 2001, pp 225–226.
Frizzera G, Kaneko Y, Sakurai M . Angioimmunoblastic lymphadenopathy and related disorders: a retrospective look in search ofdefinitions. Leukemia 1989; 3: 1–5.
Lukes RJ, Tindle BH . Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease. N Engl J Med 1975; 292: 1–8.
Lennert K . Nature, prognosis and nomenclature of angioimmunoblastic (lymphadenopathy (lymphogranulomatosis X or T-zone lymphoma). Dtsch Med Wochenschr 1979; 104: 1246–1247.
Hastrup N, Ralfkiaer E, Pallesen G . Aberrant phenotypes in peripheral T cell lymphomas. J Clin Pathol 1989; 42: 398–402.
Jones D, Dorfman DM . Phenotypic characterization of subsets of T cell lymphoma: towards a functional classification of T cell lymphoma. Leuk Lymphoma 2001; 40: 449–459.
Attygalle A, Al-Jehani R, Diss TC, Munson P, Liu H, Du MQ et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002; 99: 627–633.
Lee PS, Lin CN, Chuang SS . Immunophenotyping of angioimmunoblastic T-cell lymphomas by multiparameter flow cytometry. Pathol Res Pract 2003; 199: 539–545.
Attygalle AD, Diss TC, Munson P, Isaacson PG, Du MQ, Dogan A . CD10 Expression in Extranodal Dissemination of Angioimmunoblastic T-cell Lymphoma. Am J Surg Pathol 2004; 28: 54–61.
Blain BJ, Catovsky D . The leukemic phase of non-Hodgkin's lymphoma. J. Clin Pathol 1995; 48: 189–193.
Theodorou I, Bigorgne C, Delfau M H, Lahet C, Cochet G, Vidaud M et al. VJ rearrangements of the TCR locus in peripheral T-cell lymphomas: analysis by polymerase chain reaction and denaturing gradient gel electrophoresis. J Pathol 1996; 178: 303–310.
van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 7: 2257–2317.
Jamal S, Picker LJ, Aquino DB, McKenna RW, Dawson DB, Kroft SH . Immunophenotypic analysis of peripheral T-cell neoplasms. A multiparameter flow cytometric approach. Am J Clin Pathol 2001; 116: 512–526.
Sano S, Matsui Y, Itami S, Yoshikawa K . Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sezary syndrome. Clin Exp Immunol 1998; 113: 190–197.
Serke S, van Lessen A, Hummel M, Szczepek A, Huhn D, Stein H . Circulating CD4+ T lymphocytes with intracellular but no surface CD3 antigen in five of seven patients consecutively diagnosed with angioimmunoblastic T-cell lymphoma. Cytometry 2000; 42: 180–187.
Kim JM, Ruediger T, Fayyazi A, Mueller-Hermelink HK . Distribution of CD10, Fas (CD95) and FasL (CD95L) in angioimmunoblastic T-cell lymphoma: implications fort he pathogenesis. J Clin Pathol 2002; 55 (Suppl 1): A38.
Lu D, Lin CN, Chuang SS, Hwang WS, Huang WT . T-cell and NK/T-cell lymphomas in southern Taiwan: a study of 72 cases in a single institute. Leuk Lymphoma 2004; 45: 923–928.
Liu YJ, Johnson GD, Gordon J, MacLennan IC . Germinal centres in T-cell-dependent antibody responses. Immunol Today 1992; 13: 17–21.
Dogan A, Bagdi E, Munson P, Isaacson PG . CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol 2000; 24: 846–852.
Lee SS, Rudiger T, Odenwald T, Roth S, Starostik P, Muller-Hermelink HK . Angioimmunoblastic T cell lymphoma is derived from mature T-helper cells with varying expression and loss of detectable CD4. Int J Cancer 2003; 103: 12–20.
Cook JR, Craig FE, Swerdlow SH . Benign CD10-positive T cells in reactive lymphoid proliferations and B-cell lymphomas. Mod Pathol 2003; 16: 879–885.
Guerin S, Mari B, Maulon L, Belhacene N, Marguet D, Auberger P . CD10 plays a specific role in early thymic development. FASEB J 1997; 11: 376–381.
Salles G, Rodewald HR, Chin BS, Reinherz EL, Shipp MA . Inhibition of CD10/neutral endopeptidase 24.11 promotes B-cell reconstitution and maturation in vivo. Proc Natl Acad Sci USA 1993; 90: 7618–7622.
Mari B, Guerin S, Maulon L, Belhacene N, Farahi Far D, Imbert V, Rossi B, Peyron JF, Auberger P . Endopeptidase 24.11 (CD10/NEP) is required for phorbol ester-induced growth arrest in Jurkat T cells. FASEB J. 1997; 11: 869–879.
Cutrona G, Leanza N, Ulivi M, Melioli G, Burgio VL, Mazzarello G, Gabutti G, Roncella S, Ferrarini M . Expression of CD10 by human T cells that undergo apoptosis both in vitro and in vivo. Blood 1999; 94: 3067–3076.
Morabito F, Mangiola M, Rapezzi D, Zupo S, Oliva BM, Ferraris AM et al. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro. Haematologica. 2003; 88: 864–873.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baseggio, L., Berger, F., Morel, D. et al. Identification of circulating CD10 positive T cells in angioimmunoblastic T-cell lymphoma. Leukemia 20, 296–303 (2006). https://doi.org/10.1038/sj.leu.2404013
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404013
Keywords
This article is cited by
-
T-cell lymphomas, a challenging disease: types, treatments, and future
International Journal of Clinical Oncology (2017)
-
Overt leukemic phase: an unusual presentation of angioimmunoblastic lymphoma
Journal of Hematopathology (2016)
-
CD10 and ICOS expression by multiparametric flow cytometry in angioimmunoblastic T-cell lymphoma
Modern Pathology (2011)